被 发 现 含 有 未 标 示 西 药 的 产 品
|
| |
| Australia: Safety advisory: Li Da Weight Loss Capsules contain the undeclared substance sibutramine (English Only) |
| |
The Therapeutic Goods Administration (TGA) has tested a product labelled Li Da Weight Loss Capsules and found that the capsules contain the undeclared substance sibutramine. Consumers are advised that sibutramine is a prescription-only medicine (which was the active ingredient in Reductil). It was withdrawn in Oct 2010 after a study showed an increased risk of major cardiac events. TGA investigations have shown that a number of people in Australia may have bought the product online.
Consumers are advised to stop taking the product and take any remaining capsules to their local pharmacy for safe disposal. If they have any concerns arising from their use of this product, consult their health care practitioner.
Please refer to the following website in TGA for details:
http://www.tga.gov.au/alert/li-da-weight-loss-capsules
In Hong Kong, the above product is not a registered pharmaceutical product. Related news was previously issued by Singapore Health Sciences Authority, and was posted on the Drug Office website on 21 Jul 2018.
Ends/Thursday, Nov 1, 2018
Issued at HKT 15:00
|
| |
|
